Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair.

Ma J, Benitez JA, Li J, Miki S, Ponte de Albuquerque C, Galatro T, Orellana L, Zanca C, Reed R, Boyer A, Koga T, Varki NM, Fenton TR, Nagahashi Marie SK, Lindahl E, Gahman TC, Shiau AK, Zhou H, DeGroot J, Sulman EP, Cavenee WK, Kolodner RD, Chen CC, Furnari FB.

Cancer Cell. 2019 May 13;35(5):816. doi: 10.1016/j.ccell.2019.04.011. No abstract available.

PMID:
31085179
2.

Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients.

Chadli L, Sotthewes B, Li K, Andersen SN, Cahir-McFarland E, Cheung M, Cullen P, Dorjée A, de Vries-Bouwstra JK, Huizinga TWJ, Fischer DF, DeGroot J, Viney JL, Zheng TS, Aarbiou J, Gardet A.

Sci Rep. 2019 Mar 14;9(1):4521. doi: 10.1038/s41598-019-41153-w.

3.

Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair.

Ma J, Benitez JA, Li J, Miki S, Ponte de Albuquerque C, Galatro T, Orellana L, Zanca C, Reed R, Boyer A, Koga T, Varki NM, Fenton TR, Nagahashi Marie SK, Lindahl E, Gahman TC, Shiau AK, Zhou H, DeGroot J, Sulman EP, Cavenee WK, Kolodner RD, Chen CC, Furnari FB.

Cancer Cell. 2019 Mar 18;35(3):504-518.e7. doi: 10.1016/j.ccell.2019.01.020. Epub 2019 Feb 28. Erratum in: Cancer Cell. 2019 May 13;35(5):816.

PMID:
30827889
4.

A Model of Transcorporeal Communication: Communication Toward/With/to the Deceased.

DeGroot JM.

Omega (Westport). 2018 Nov;78(1):43-66. doi: 10.1177/0030222816683195. Epub 2016 Dec 7.

PMID:
30286686
5.

Communication Apprehension About Death, Religious Group Affiliation, and Religiosity: Predictors of Organ and Body Donation Decisions.

Carmack HJ, DeGroot JM.

Omega (Westport). 2018 Aug 10:30222818793294. doi: 10.1177/0030222818793294. [Epub ahead of print]

PMID:
30096990
6.

Women supporting women: Supportive/educative groups for ethnically diverse, urban, impoverished women dealing with depression and anxiety.

Doornbos MM, Zandee GL, Timmermans B, Moes J, DeGroot J, DeMaagd-Rodriguez M, Smit-Scholman J, Zietse M, Heitsch E, Quist M.

Arch Psychiatr Nurs. 2018 Aug;32(4):524-529. doi: 10.1016/j.apnu.2018.02.007. Epub 2018 Feb 14.

PMID:
30029743
7.

R.I.P. Kutner: Parasocial Grief Following the Death of a Television Character.

DeGroot JM, Leith AP.

Omega (Westport). 2018 Aug;77(3):199-216. doi: 10.1177/0030222815600450. Epub 2015 Aug 17.

PMID:
29940828
8.

Profiles of brain metastases: Prioritization of therapeutic targets.

Ferguson SD, Zheng S, Xiu J, Zhou S, Khasraw M, Brastianos PK, Kesari S, Hu J, Rudnick J, Salacz ME, Piccioni D, Huang S, Davies MA, Glitza IC, Heymach JV, Zhang J, Ibrahim NK, DeGroot JF, McCarty J, O'Brien BJ, Sawaya R, Verhaak RGW, Reddy SK, Priebe W, Gatalica Z, Spetzler D, Heimberger AB.

Int J Cancer. 2018 Dec 1;143(11):3019-3026. doi: 10.1002/ijc.31624. Epub 2018 Oct 9.

9.

Antisense Long Non-Coding RNAs Are Deregulated in Skin Tissue of Patients with Systemic Sclerosis.

Messemaker TC, Chadli L, Cai G, Goelela VS, Boonstra M, Dorjée AL, Andersen SN, Mikkers HMM, van 't Hof P, Mei H, Distler O, Draisma HHM, Johnson ME, Orzechowski NM, Simms RW, Toes REM, Aarbiou J, Huizinga TW, Whitfield ML, DeGroot J, de Vries-Bouwstra J, Kurreeman F.

J Invest Dermatol. 2018 Apr;138(4):826-835. doi: 10.1016/j.jid.2017.09.053. Epub 2017 Nov 24.

10.

Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial.

Waksman R, Piegari GN, Kabour A, Cannon L, Wang J, Adams G, Solankhi N, Smeglin A, Kereiakes DJ, Leiboff R, Spad MA, Torguson R, Chandra N, Bastian R, DeGroot J, Kayo MW, Stoll HP, Garcia-Garcia HM.

Cardiovasc Revasc Med. 2017 Oct - Nov;18(7):475-481. doi: 10.1016/j.carrev.2017.07.017. Epub 2017 Jul 31.

PMID:
28923692
11.

Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients.

Cachia D, Elshafeey NA, Kamiya-Matsuoka C, Hatami M, Alfaro-Munoz KD, Mandel JJ, Colen R, DeGroot JF.

J Neurooncol. 2017 Oct;135(1):75-81. doi: 10.1007/s11060-017-2550-5. Epub 2017 Jul 12.

PMID:
28702781
12.

Program Success of Mental Health Clients in Day Reporting Centers.

McGregor B, Brown E, Yan F, Mitchell C, Robinson C, DeGroot J, Braithwaite R.

J Health Care Poor Underserved. 2016;27(2A):194-213. doi: 10.1353/hpu.2016.0060.

PMID:
27133519
13.

Mandatory labeling requirements and over-the-counter cough and cold medication use in early childhood.

DeGroot J, Anderson LN, Chen Y, Birken CS, Parkin PC, Carsley S, Khovratovich M, Mamdani M, Maguire JL; TARGet Kids! collaboration.

Can J Public Health. 2016 Mar 16;106(8):e477-82. doi: 10.17269/cjph.106.5148.

PMID:
26986907
14.

Providing Novice Navigators With a GPS for Role Development: Oncology Nurse Navigator Competency Project.

McMullen L, Banman T, DeGroot JM, Scott S, Srdanovic D, Mackey H.

Clin J Oncol Nurs. 2016 Feb;20(1):33-8. doi: 10.1188/16.CJON.20-01AP.

PMID:
26800404
15.

PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier.

Vlaming ML, Läppchen T, Jansen HT, Kivits S, van Driel A, van de Steeg E, van der Hoorn JW, Sio CF, Steinbach OC, DeGroot J.

Nucl Med Biol. 2015 Nov;42(11):833-41. doi: 10.1016/j.nucmedbio.2015.07.004. Epub 2015 Jul 15.

PMID:
26264927
16.

Severe iron-deficiency anaemia and feeding practices in young children.

Parkin PC, DeGroot J, Maguire JL, Birken CS, Zlotkin S.

Public Health Nutr. 2016 Mar;19(4):716-22. doi: 10.1017/S1368980015001639. Epub 2015 Jun 1.

PMID:
26027426
17.

Comparison of isotonic and hypotonic intravenous maintenance fluids: a randomized clinical trial.

Friedman JN, Beck CE, DeGroot J, Geary DF, Sklansky DJ, Freedman SB.

JAMA Pediatr. 2015 May;169(5):445-51. doi: 10.1001/jamapediatrics.2014.3809.

PMID:
25751673
18.

Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1∗15 and OATP1B3.

van de Steeg E, Venhorst J, Jansen HT, Nooijen IH, DeGroot J, Wortelboer HM, Vlaming ML.

Eur J Pharm Sci. 2015 Apr 5;70:29-36. doi: 10.1016/j.ejps.2015.01.004. Epub 2015 Jan 17.

PMID:
25603031
19.

Predictors of long length of stay in infants hospitalized with urinary tract infection.

McMullen JA, Mahant S, DeGroot JM, Stephens D, Parkin PC.

Hosp Pediatr. 2014 Sep;4(5):291-7. doi: 10.1542/hpeds.2014-0020.

20.

Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group.

Alexander BM, Galanis E, Yung WK, Ballman KV, Boyett JM, Cloughesy TF, Degroot JF, Huse JT, Mann B, Mason W, Mellinghoff IK, Mikkelsen T, Mischel PS, O'Neill BP, Prados MD, Sarkaria JN, Tawab-Amiri A, Trippa L, Ye X, Ligon KL, Berry DA, Wen PY.

Neuro Oncol. 2015 Feb;17(2):180-8. doi: 10.1093/neuonc/nou154. Epub 2014 Aug 26. Review.

21.
22.

Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.

Hamza MA, Mandel JJ, Conrad CA, Gilbert MR, Yung WK, Puduvalli VK, DeGroot JF.

J Neurooncol. 2014 Aug;119(1):135-40. doi: 10.1007/s11060-014-1460-z. Epub 2014 May 7.

23.

Canadian parents' attitudes and beliefs about bicycle helmet legislation in provinces with and without legislation.

Parkin PC, Degroot J, Macpherson A, Fuselli P, Macarthur C.

Chronic Dis Inj Can. 2014 Feb;34(1):8-11. English, French.

24.

"For whom the bell tolls": emotional rubbernecking in Facebook memorial groups.

DeGroot JM.

Death Stud. 2014 Jan-Jun;38(1-5):79-84. doi: 10.1080/07481187.2012.725450. Epub 2013 Aug 9.

PMID:
24517705
25.

"It may not be pretty, but it's honest": examining parental grief on the Callapitter blog.

DeGroot JM, Carmack HJ.

Death Stud. 2013 May-Jun;37(5):448-70.

PMID:
24517565
26.

Predictors of bacteremia among children with sickle cell disease presenting with fever.

Savlov D, Beck CE, DeGroot J, Odame I, Friedman JN.

J Pediatr Hematol Oncol. 2014 Jul;36(5):384-8. doi: 10.1097/MPH.0000000000000070.

PMID:
24309605
27.

Using community-based participatory research to explore social determinants of women's mental health and barriers to help-seeking in three urban, ethnically diverse, impoverished, and underserved communities.

Doornbos MM, Zandee GL, DeGroot J, De Maagd-Rodriguez M.

Arch Psychiatr Nurs. 2013 Dec;27(6):278-84. doi: 10.1016/j.apnu.2013.09.001. Epub 2013 Oct 10.

PMID:
24238007
28.

Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial.

Lenane P, Macarthur C, Parkin PC, Krafchik B, DeGroot J, Khambalia A, Pope E.

JAMA Dermatol. 2014 Jan;150(1):47-50. doi: 10.1001/jamadermatol.2013.5764.

PMID:
24226568
29.

Combined analysis of pharmacokinetic and efficacy data of preclinical studies with statins markedly improves translation of drug efficacy to human trials.

van de Steeg E, Kleemann R, Jansen HT, van Duyvenvoorde W, Offerman EH, Wortelboer HM, Degroot J.

J Pharmacol Exp Ther. 2013 Dec;347(3):635-44. doi: 10.1124/jpet.113.208595. Epub 2013 Sep 18.

PMID:
24049060
30.

Successful discharge of children with gastroenteritis requiring intravenous rehydration.

Freedman SB, DeGroot JM, Parkin PC.

J Emerg Med. 2014 Jan;46(1):9-20. doi: 10.1016/j.jemermed.2013.04.044. Epub 2013 Aug 30.

PMID:
23993936
31.

Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.

Batchelor TT, Mulholland P, Neyns B, Nabors LB, Campone M, Wick A, Mason W, Mikkelsen T, Phuphanich S, Ashby LS, Degroot J, Gattamaneni R, Cher L, Rosenthal M, Payer F, Jürgensmeier JM, Jain RK, Sorensen AG, Xu J, Liu Q, van den Bent M.

J Clin Oncol. 2013 Sep 10;31(26):3212-8. doi: 10.1200/JCO.2012.47.2464. Epub 2013 Aug 12.

32.

Prostate cancer-specific survival differences in patients treated by radical prostatectomy versus curative radiotherapy.

Degroot JM, Brundage MD, Lam M, Rohland SL, Heaton J, Mackillop WJ, Siemens DR, Groome PA.

Can Urol Assoc J. 2013 May-Jun;7(5-6):E299-305. doi: 10.5489/cuaj.11294. Epub 2013 May 13.

33.

Non-Western immigrant children have lower 25-hydroxyvitamin D than children from Western families.

Omand JA, Darling PB, Parkin PC, Birken CS, Khovratovich M, Thorpe KE, Carsley S, DeGroot J, Maguire JL; TARGet Kids! Collaboration.

Public Health Nutr. 2014 Jul;17(7):1547-54. doi: 10.1017/S1368980013001328. Epub 2013 May 24. Erratum in: Public Health Nutr. 2014 Jul;17(7):1668.

PMID:
23701731
34.

Skin pentosidine in very early hip/knee osteoarthritis (CHECK) is not a strong independent predictor of radiographic progression over 5 years follow-up.

Vos PA, Welsing PM, deGroot J, Huisman AM, Oostveen JC, Reijman M, Damen J, Mastbergen SC, Lafeber FP.

Osteoarthritis Cartilage. 2013 Jun;21(6):823-30. doi: 10.1016/j.joca.2013.03.006. Epub 2013 Mar 27.

35.

Modifiable determinants of serum 25-hydroxyvitamin D status in early childhood: opportunities for prevention.

Maguire JL, Birken CS, Khovratovich M, Degroot J, Carsley S, Thorpe KE, Mamdani M, Parkin PC; TARGet Kids! Collaboration.

JAMA Pediatr. 2013 Mar 1;167(3):230-5. doi: 10.1001/2013.jamapediatrics.226.

PMID:
23318560
36.
37.

Drug-drug interactions between rosuvastatin and oral antidiabetic drugs occurring at the level of OATP1B1.

van de Steeg E, Greupink R, Schreurs M, Nooijen IH, Verhoeckx KC, Hanemaaijer R, Ripken D, Monshouwer M, Vlaming ML, DeGroot J, Verwei M, Russel FG, Huisman MT, Wortelboer HM.

Drug Metab Dispos. 2013 Mar;41(3):592-601. doi: 10.1124/dmd.112.049023. Epub 2012 Dec 17.

PMID:
23248200
38.

Integrated phase II/III clinical trials in oncology: a case study.

Wang M, Dignam JJ, Zhang QE, DeGroot JF, Mehta MP, Hunsberger S.

Clin Trials. 2012 Dec;9(6):741-7. doi: 10.1177/1740774512464724. Epub 2012 Nov 22. Review.

PMID:
23180870
39.

Desired mental health resources for urban, ethnically diverse, impoverished women struggling with anxiety and depression.

Doornbos MM, Zandee GL, DeGroot J, Warpinski M.

Qual Health Res. 2013 Jan;23(1):78-92. doi: 10.1177/1049732312465018.

PMID:
23166153
40.

Clinging to any bit of joy: urban, ethnically diverse, impoverished women's descriptions of anxiety and depression.

Doornbos MM, Zandee GL, Degroot J.

Arch Psychiatr Nurs. 2012 Dec;26(6):437-47. doi: 10.1016/j.apnu.2011.12.007. Epub 2012 Feb 14.

PMID:
23164400
41.

Office-based randomized controlled trial to reduce screen time in preschool children.

Birken CS, Maguire J, Mekky M, Manlhiot C, Beck CE, Degroot J, Jacobson S, Peer M, Taylor C, McCrindle BW, Parkin PC.

Pediatrics. 2012 Dec;130(6):1110-5. doi: 10.1542/peds.2011-3088. Epub 2012 Nov 5.

PMID:
23129085
42.

Maintaining relational continuity with the deceased on Facebook.

DeGroot JM.

Omega (Westport). 2012;65(3):195-212.

PMID:
23057245
43.

Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis.

van Spil WE, Jansen NW, Bijlsma JW, Reijman M, DeGroot J, Welsing PM, Lafeber FP.

Osteoarthritis Cartilage. 2012 Jul;20(7):745-54. doi: 10.1016/j.joca.2012.04.004. Epub 2012 Apr 11.

44.

Elevation of cartilage AGEs does not accelerate initiation of canine experimental osteoarthritis upon mild surgical damage.

Vos PA, DeGroot J, Barten-van Rijbroek AD, Zuurmond AM, Bijlsma JW, Mastbergen SC, Lafeber FP.

J Orthop Res. 2012 Sep;30(9):1398-404. doi: 10.1002/jor.22092. Epub 2012 Mar 2.

45.

In end stage osteoarthritis, cartilage tissue pentosidine levels are inversely related to parameters of cartilage damage.

Vos PA, Mastbergen SC, Huisman AM, de Boer TN, DeGroot J, Polak AA, Lafeber FP.

Osteoarthritis Cartilage. 2012 Mar;20(3):233-40. doi: 10.1016/j.joca.2011.12.007. Epub 2011 Dec 21.

46.

Infrapatellar fat pad of patients with end-stage osteoarthritis inhibits catabolic mediators in cartilage.

Bastiaansen-Jenniskens YM, Clockaerts S, Feijt C, Zuurmond AM, Stojanovic-Susulic V, Bridts C, de Clerck L, DeGroot J, Verhaar JA, Kloppenburg M, van Osch GJ.

Ann Rheum Dis. 2012 Feb;71(2):288-94. doi: 10.1136/ard.2011.153858. Epub 2011 Oct 13.

PMID:
21998115
47.

Automated synthesis of [18F]gefitinib on a modular system.

Läppchen T, Vlaming ML, Custers E, Lub J, Sio CF, DeGroot J, Steinbach OC.

Appl Radiat Isot. 2012 Jan;70(1):205-9. doi: 10.1016/j.apradiso.2011.09.005. Epub 2011 Sep 17.

PMID:
21975107
48.

Patterns of fatal machine rollovers in Canadian agriculture.

DeGroot JM, Isaacs C, Pickett W, Brison RJ.

Chronic Dis Inj Can. 2011 Jun;31(3):97-102.

49.

Clinical trial end points for high-grade glioma: the evolving landscape.

Reardon DA, Galanis E, DeGroot JF, Cloughesy TF, Wefel JS, Lamborn KR, Lassman AB, Gilbert MR, Sampson JH, Wick W, Chamberlain MC, Macdonald DR, Mehta MP, Vogelbaum MA, Chang SM, Van den Bent MJ, Wen PY.

Neuro Oncol. 2011 Mar;13(3):353-61. doi: 10.1093/neuonc/noq203. Epub 2011 Feb 9. Review.

50.

Integration of efficacy, pharmacokinetic and safety assessment of interleukin-1 receptor antagonist in a preclinical model of arthritis.

Zuurmond AM, Koudijs A, van El B, Doornbos RP, van Manen-Vernooij BC, Bastiaans JH, Penninks AH, van Bilsen JH, Cnubben NH, Degroot J.

Regul Toxicol Pharmacol. 2011 Apr;59(3):461-70. doi: 10.1016/j.yrtph.2011.01.014. Epub 2011 Feb 12.

PMID:
21300126

Supplemental Content

Loading ...
Support Center